HOB Biotech GroupLtd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
John Li
Chief executive officer
CN¥1.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.7yrs |
| CEO ownership | 12.2% |
| Management average tenure | 3.8yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
HOB Biotech GroupLtd (SHSE:688656) Seems To Use Debt Quite Sensibly
Jan 24
HOB Biotech Group Corp.,Ltd's (SHSE:688656) Popularity With Investors Under Threat As Stock Sinks 29%
Dec 23HOB Biotech GroupLtd's (SHSE:688656) Anemic Earnings Might Be Worse Than You Think
Nov 04Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 43%
Oct 08Subdued Growth No Barrier To HOB Biotech Group Corp.,Ltd's (SHSE:688656) Price
Jul 04HOB Biotech GroupLtd's (SHSE:688656) Earnings Are Weaker Than They Seem
May 06Earnings Not Telling The Story For HOB Biotech Group Corp.,Ltd (SHSE:688656) After Shares Rise 25%
Mar 08CEO
John Li (62 yo)
Mr. John Li serves as the Chairman & General Manager of HOB Biotech Group Co., Ltd and serves its Director since July 19, 2017. Mr. Li founded HOB Biotech in 2007. Mr. Li worked for multi-national corporat...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | no data | CN¥1.63m | 12.18% CN¥ 1.1b | |
| Chief Financial Officer | 2.7yrs | CN¥610.00k | no data | |
| Director & Deputy GM | 3.8yrs | CN¥1.95m | 0.00032% CN¥ 27.9k | |
| Secretary | 3yrs | CN¥451.00k | no data | |
| Deputy General Manager | 4.2yrs | CN¥1.27m | no data | |
| Deputy General Manager | 4.2yrs | CN¥949.00k | no data | |
| Accounting Supervisor | no data | no data | no data |
Experienced Management: 688656's management team is considered experienced (3.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & GM | 8.7yrs | CN¥1.63m | 12.18% CN¥ 1.1b | |
| Director & Deputy GM | 3.8yrs | CN¥1.95m | 0.00032% CN¥ 27.9k | |
| Vice Chairman of the Board | 12.4yrs | CN¥674.00k | 0.042% CN¥ 3.7m | |
| Chairman of the Supervisory Board | 8.7yrs | no data | no data | |
| Supervisor | 8.7yrs | no data | no data | |
| Supervisor | 4.8yrs | no data | no data | |
| Independent Director | 2.7yrs | CN¥40.00k | no data | |
| Independent Director | 2.7yrs | CN¥40.00k | no data | |
| Independent Director | 2.7yrs | CN¥40.00k | no data | |
| Director | 2.7yrs | CN¥941.00k | no data |
Experienced Board: 688656's board of directors are considered experienced (4.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/13 16:19 |
| End of Day Share Price | 2026/03/13 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
HOB Biotech Group Corp.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.